Searching for the optimal management of hepatitis C patients after liver transplantation

Transplant International

Volumn 11, Issue SUPPL. 1, 1998, Pages

  Platz, K P ^a   Mueller, A R ^a   Berg, T ^a   Neuhaus, R ^a   Hopf, U ^a   Lobeck, H ^a   Neuhaus, P ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Hepatitis C; Liver transplantation

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; HEPATITIS C; HUMAN; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATION;

HEPATITIS C; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS;

EID: 0031602426     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.1998.tb01117.x     Document Type: Article

References (17)

1. Fukumoto T, Berg T, Ku Y, Bechstein WO, Hopf U, Neuhaus P (1997) Kinetics of hepatitis C viremia after orthotopic liver transplantation. Transplant Proc 29: 511-513
2. König V, Bauditz J, Lobeck H, et al (1992) Hepatitis C reinfection after orthotopic liver transplantation. Hepatology 16: 1137-1143
3. Lake JR, Wright T, Ferrell L, Roberts J, Ascher N (1993) Hepatitis B and C in liver transplantation. Transplant Proc 25: 2006-2009
4. Arnold JC, Kraus T, Otto G, et al (1992) Recurrent hepatitis C virus after liver transplantation. Transplant Proc 24: 2646-2647
5. Feray C, Samuel D, Thiers V, et al (1992) Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest 89: 1361-1365
6. Wright TL, Donegan E, Hsu HH, et al (1992) Recurrent and aquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 103: 317-322
7. Poterucha JJ, Rakela J, Lumeng L, Lee C-H, Taswell HF, Wiesner RH (1992) Diagnosis of chronic hepatitis C after liver transplantation by detection of viral sequences with polymerase chain reaction. Hepatology 15: 42-45
8. Platz K-P, Mueller AR, Neuhaus R, Keck HH, Lemmens HP, Hopf U, Neuhaus P (1996) Hepatitis C: indication for anti-viral therapy? Transpl Int 9 (suppl 1): S198-S201
9. Mueller AR, Platz KP, Berg T, Fukumoto T, Guckelberger O, Neuhaus R, Bechstein WO, Hopf U, Lobeck H, Neuhaus P (1996) Long-term follow up in hepatitis C patients with respect to immunosuppression. Transplant Proc 28: 3243-3244
10. Sheiner PA, Schwartz ME, Mor E, et al (1995) Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after liver transplantation. Hepatology 21: 30-34
11. Mueller AR, Platz K-P, Christe W, Bechstein WO, Blumhardt G, Neuhaus P (1994) Severe neurotoxicity after liver transplantation: association between FK506 therapy and hepatitis C virus disease. Transplant Proc 26: 3131-3132
12. Mueller AR, Platz K-P, Bechstein WO, et al (1995) The optimal immunosuppressant after liver transplantation according to diagnosis: cyclosporine A or FK506. Clin Transplant 9: 176-184
13. Neuhaus P, Bechstein WO, Blumhardt G, et al (1993) Comparison of quadruple immunosuppression after liver transplantation with ATG or IL-2 receptor antibody. Transplantation 55: 1320-1327
14. Neuhaus P, Blumhardt G, Bechstein WO, et al (1995) Comparison of FK506- and cyclosporine A-based immunosuppression in primary orthotopic liver transplantation. A single center experience. Transplantation 59: 31-40
15. Snover DC, Freese DK, Sharp HC, Bloomer JR, Najarian JA, Asher N (1987) Liver allograft rejection: an analysis of the use of biopsy in determining outcome of rejection. Am J Surg Path 11: 1-10
16. Demetris AJ, Qquian S, Sun A, Fung JJ (1990) Liver allograft rejection: an overview of morphological findings. Am J Surg Path 14 (suppl 1): 49-63
17. Shah G, Demetris AJ, Gavaler JS, et al (1992) Incidence, prevalence, and clinical course of hepatitis C following liver transplantation. Gastroenterology 103: 323-324